Back to JACOBS LEVY EQUITY MANAGEMENT, INC

REGN
Showing 8 of 10 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in REGENERON PHARMACEUTICALS

JACOBS LEVY EQUITY MANAGEMENT, INC holds 214,160 shares of REGN (REGENERON PHARMACEUTICALS), worth $165.5M as of 2026-Q1. The position was decreased (-19.2% shares). REGN represents 0.7% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$165.5M

Current Shares

214,160

Total Value Change

+$151.4M

Total Shares Change

+200,782

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
214,160
-19.2%
$165.5M0.7%$766.66
0
2025-Q4
Decreased
264,991
-8.0%
$204.5M0.8%$773.94
0
2025-Q3
Increased
287,881
+22.9%
$161.9M0.6%$560.05
52
2025-Q2
Increased
234,267
+313x
$123M0.5%$519.56
58
2025-Q1
Decreased
747
-11.8%
$473,7700.0%$634.66
0
2024-Q4
Decreased
847
-96.4%
$603,3440.0%$698.71
0
2024-Q3
Increased
23,591
+76.3%
$24.8M0.1%$1,036.94
43
2024-Q2
Increased
13,378
+3595.6%
$14.1M0.1%$1,045.23
45

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used